COVID-19血栓:区分病理,机械和表型特征和管理
Richard C Becker1, Udaya S Tantry2, Muhammad Khan3
1Cardiovascular Center, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA. richard.becker@uc.edu.
Journal of thrombosis and thrombolysis
|August 23, 2024
概括
COVID-19显著增加了血栓形成的风险,影响了所有疾病严重程度和阶段的小型和大型血管. 了解这些独特的血栓事件对于有效的患者管理和预防至关重要.
科学领域:
- 心血管医学 心血管医学
- 传染性疾病 传染性疾病
- 病理学 病理学 病理学
背景情况:
- COVID-19与血栓形成的风险增加密切相关.
- 血栓事件涉及小 (微) 和大 (宏) 血管,影响静脉和动脉系统.
- 这些事件发生在各种疾病严重程度和疾病阶段,从超急性到慢性.
研究的目的:
- 审查COVID-19患者静脉,动脉和微血管血栓的临床特征,病理方面和机制.
- 为了增强对SARS-CoV-2感染中血栓形成倾向的理解.
- 为改善查,监测,预防和管理策略奠定基础.
主要方法:
- 对临床和病理学数据的集中文献综述.
- 分析不同COVID-19疾病严重程度和阶段的血栓形成特征.
- 潜在机制的合成 COVID-19相关血栓形成的潜在机制.
主要成果:
- 血栓形成是COVID-19的一个标志,影响着各种血管床.
- 在早期感染阶段的重症患者和晚期的轻度至中度病例中观察到事件.
- 显著的临床特征和病理成分是这些血栓事件的特征.
结论:
- 与COVID-19相关的血栓形成呈现出不同阶段和疾病严重程度的不同模式.
- 进一步了解这些机制对于开发有针对性的干预措施至关重要.
- 本综述为优化COVID-19相关血栓瘤患者的临床护理提供了见解.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
01:16Clot Retraction and Fibrinolysis
4.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.9K
01:24Disorders of Hemostasis
756
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
756
01:09Coagulation
5.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.6K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
6.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.5K